Table 1.
Study Participant Characteristics
| n = 100 | No. = % |
|---|---|
| Age (y), mean [SD, range] | 41.9 [17.4, 19–86] |
| 19–25 | 19 |
| 26–35 | 34 |
| 36–45 | 10 |
| 46–55 | 9 |
| 56–65 | 11 |
| 66–75 | 14 |
| 76+ | 3 |
| Race/ethnicity* | |
| Asian/Pacific Islander | 8 |
| Black | 10 |
| White | 68 |
| Hispanic | 21 |
| Other/choose not to disclose | 19 |
| Gender* | |
| Man | 40 |
| Woman | 35 |
| Cisgender man | 0 |
| Cisgender woman | 1 |
| Transgender man | 11 |
| Transgender woman | 28 |
| Transmasculine | 2 |
| Transfeminine | 6 |
| Nonbinary | 6 |
| Agender | 1 |
| Gender queer/gender nonconforming | 6 |
| Other/choose not to disclose | 0 |
| Sexuality* | |
| Straight | 61 |
| Gay | 8 |
| Lesbian | 8 |
| Bisexual | 14 |
| Pansexual | 14 |
| Queer | 15 |
| Asexual | 0 |
| Other/choose not to disclose | 2 |
| Gender-affirming surgical history* | |
| Vaginoplasty | 33 |
| Phalloplasty | 16 |
| Metoidioplasty | 1 |
| None | 50 |
| Currently taking hormonal therapy* | |
| Yes, testosterone | 19 |
| Yes, estrogen | 35 |
| Yes, progesterone | 15 |
| Yes, other | 5 |
| No | 45 |
*
Participants selected all that applied.